Foldax

Foldax, founded in 2013 and based in Salt Lake City, Utah, is dedicated to developing synthetic heart valves aimed at significantly reducing costs compared to existing artificial or tissue valves. The company’s core mission is to provide durable, non-thrombogenic aortic and mitral valves that enhance patients' quality of life. Foldax leverages its proprietary LifePolymer™ material and robotic manufacturing processes to produce TRIA™ heart valves, which are designed to last a lifetime. The company focuses on revolutionizing heart valve therapy through innovative design and advanced materials.

Notable figures associated with Foldax include its founders and key investors who have supported the company's vision of transforming heart valve therapy. Foldax has achieved significant milestones, including successful pre-clinical studies demonstrating the efficacy of its LifePolymer™ material. The company's impact is evident in its potential to offer more durable and cost-effective heart valve solutions, potentially extending beyond heart valves to other medical applications. Foldax's pioneering approach in the manufacturing sector positions it as a leader in medical device innovation.